Literature DB >> 8980917

How harmless is FFA enhancement?

C Tesserommatis1, C Tsopanakis, G Symeonoglou, M Loukissa, E Kouvarou, D D Varonos.   

Abstract

Standard heparin as well as low molecular weight heparin (LMWH) increase lipid levels in serum. It has been reported that a diet rich in long chain saturated fatty acids can enhance the susceptibility to experimental thrombosis. The mechanism by which serum fatty acids may provoke thrombosis is not clear. It is possible that the fatty acids change the properties of the cell membrane and thereby modify the response of platelets to aggregating agents. Heparin and its LMW fractions, by mobilising lipoprotein lipase that hydrolyses serum triglycerides (TG), cause the serum TG to increase, a well known "clearing effect' of heparin in turbid lipemic plasma. This effect may have no significance when it lasts for a short time; however, a long-lasting heparin effect on TG serum levels may have important consequences. The purpose of this study was to examine the time span of the action of heparin and its fractions and to investigate variations in the concentration of digoxin, which is a compound with narrow therapeutic width. The investigated substances after 2 days administration, provoked serum concentration increases of free fatty acids (FFA), TG and HDL-C. Seven days after stopping drug administration, FFA and HDL-C levels remained high, while triglycerides declined. Serum total cholesterol remained unchanged throughout. Digoxin levels increased non-significantly after heparin administration and during swimming stress, while a lipid diet caused a serum digoxin concentration increase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980917     DOI: 10.1007/bf03189715

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  10 in total

1.  [THE EFFECT OF REPEATED HEPARIN INJECTIONS ON THE TOTAL FAT AND CHOLESTEROL CONTENT OF THE SERUM IN NORMAL RATS].

Authors:  P C VUKYDIS; A N GRANITSAS; D D VARONOS; G C NIKITOPULU
Journal:  Klin Wochenschr       Date:  1963-09-15

2.  Free digitoxin in normal and albumin-deficient serum as estimated by centrifugal ultrafiltration.

Authors:  S H Segalstad; P Kierulf; K Langseth-Manrique; L Storstein
Journal:  Clin Chem       Date:  1988-04       Impact factor: 8.327

3.  Changes in serum lipids with the presence of various factors.

Authors:  C Tesserommatis; C Tsopanakis; D Varonos
Journal:  Beitr Infusionsther       Date:  1988

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Thrombogenicity and atherogenicity of dietary fatty acids in rats.

Authors:  S Renaud
Journal:  J Atheroscler Res       Date:  1968 Jul-Aug

6.  Relationship between the type of dietary fatty acid and arterial thrombosis tendency in rats.

Authors:  G Hornstra; R N Lussenburg
Journal:  Atherosclerosis       Date:  1975 Nov-Dec       Impact factor: 5.162

7.  Digoxin-like immunoreactive substance in chronic hemodialysis patients: effect on digitoxin radioimmunoassay.

Authors:  J A Walker; G B Bialy; V C Walker; R A Sherman; R P Eisinger
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

8.  Cholesterol determination in high-density lipoproteins separated by three different methods.

Authors:  M F Lopes-Virella; P Stone; S Ellis; J A Colwell
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

9.  Studies on digitalis. VI. The effect of heparin on serum protein binding of digitoxin and digoxin.

Authors:  L Storstein; H Janssen
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

10.  Dietary manipulation of plasma albumin concentration.

Authors:  P G Lunn; S Austin
Journal:  J Nutr       Date:  1983-09       Impact factor: 4.798

  10 in total
  5 in total

Review 1.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

2.  Light induced changes in quinolone levels in rat serum and tissues.

Authors:  C Tesseromatis; A Kotsiou; C Mourouzis; Th Saranteas; A Potamianou; E Vairactaris
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Oct-Dec       Impact factor: 2.441

3.  Alterations in cefalosporin levels in the serum and mandible of hyperlipaedemic rats after co-administration of ibuprofen.

Authors:  E Tsivou; I Melakopoulos; A Kotsiou; S Anagnostopoulou; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Stress can affect drug pharmacokinetics via serum/tissues protein binding and blood flow rate alterations.

Authors:  Kotsiou Antonia; Alevizou Anastasia; Christine Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-12-16       Impact factor: 2.441

5.  Changes in serum levels of quinolones in rats under the influence of experimental trauma.

Authors:  A Trichilis; C Tesserommatis; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.